Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Interventions

OTHER

Interview

Complete cognitive debriefing interview

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete MDASI questionnaire

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02515383 - Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version) | Biotech Hunter | Biotech Hunter